ClinicalTrials.Veeva

Menu

Safety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic Procedures (MARS GI)

L

Levita Magnetics

Status

Completed

Conditions

Bariatric Surgery Candidate
Other Disease
Cholelithiases

Treatments

Device: Dual Robotic Arm Accessory (DRAA)

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and feasibility of the Levita Dual Robotic Arm Accessory (DRAA) used with the Levita Magnetic Surgical System (MSS)

Full description

Prospective, multi-center, single-arm, open label study designed to assess the safety and feasibility of the use of the Dual Robotic Arm Accessory with the Levita Magnetic Surgical System in laparoscopic procedures

Enrollment

22 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Subject is at least 18 years of age

    • Subject is scheduled to undergo elective laparoscopic procedure
    • Subject signs a written Informed Consent Form (ICF) to participate in the study prior to any study required procedures

Exclusion criteria

  • • Subjects with pacemakers, defibrillators, or other electromedical implants

    • Subjects with ferromagnetic implants
    • Subjects with significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure)
    • Subjects with a clinical history of impaired coagulation confirmed by abnormal blood tests
    • Subject has an anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use
    • Subject is pregnant or wishes to become pregnant during the length of study participation
    • Subject is not likely to comply with the follow-up evaluation schedule
    • Subject is participating in a clinical trial of another investigational drug or device Prisoner or under incarceration

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

22 participants in 1 patient group

DRAA (Dual Robotic Arm Accessory)
Experimental group
Description:
Levita has developed a Robotic Platform (DRAA) to assist in external management of the controlling magnet and the laparoscopic camera, which would give better control of surgical tools to the surgeon.
Treatment:
Device: Dual Robotic Arm Accessory (DRAA)

Trial documents
1

Trial contacts and locations

3

Loading...

Central trial contact

Vivian Soto

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems